We’re committed to solving a deadly problem. Each year, 1.7 million Americans get hospital-acquired infections; 99,000 die as a result. Costs associated with HAI are estimated at upwards of $35 billion annually. Meanwhile, bacteria are becoming stronger, more resistant to antibiotics. Fungi and viruses are harder to control and kill. Now, BioSafe Technologies is ready to launch a new class of light-activated synthetic antimicrobials fundamentally different from all others. We want you to join us.
Effective against a wide range of disease-causing pathogens.
The only antimicrobial that signals the need for re-application.
Light-induced Reactive Oxygen Species (ROS) kills antibiotic-resistant strains of bacteria with ease.
Control biofilm growth, with our self-cleaning surfaces.
Easier and more effective than NanoSilver.
Retain killing power in the presence of commonly used detergents.
Deadly to microbes, but tested and proven not to irritate skin.
Today health care and biodefense, tomorrow food service. Killing microbes is our strength.
OUR TECHNOLOGY IS DISRUPTIVE, representing a new class of synthetic antimicrobials set to revolutionize how disinfectants are viewed and used.
Our light-activated compounds are fundamentally different from traditional antimicrobials, dealing broad-spectrum damage to pathogenic microbes in a detergent-like manner. So novel, our technology has secured eight patents to date and another nine are pending or provisional.
OUR LEAD PRODUCT IS A DISPOSABLE DISINFECTING WIPE treated with BioSafe’s patented light-activated antimicrobial, created for healthcare environments to eradicate bacteria, fungi and viruses, and prevent the regrowth of deadly biofilms.
Appropriate for non-porous surfaces such as glass, plastic and metal, these disinfecting wipes keep surfaces contamination-free for up to four hours. A quick audit with an ultraviolet light instantly and accurately determines when it’s time to clean again.
We all want a cleaner, safer world – and better ways to get there. BioSafe is at the forefront of commercializing a groundbreaking class of antimicrobials proven to elevate the eradication of a broad spectrum of pathogenic microbes threatening health care, foodservice and public health.
We’re now engaging strategic partners.